These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 11499247)

  • 1. [Risk factors in hypertension: a disease with fatal consequences].
    Mutschler E; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2001; 30(4):279. PubMed ID: 11499247
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application to the internist practice. The place of AT1 receptor antagonists].
    Dusleag H
    Pharm Unserer Zeit; 2001; 30(4):322-5. PubMed ID: 11499258
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations regarding AT1 receptor antagonists. Selection criteria of the drug commission].
    Kämmerer W; Sigmund M
    Pharm Unserer Zeit; 2001; 30(4):327-30. PubMed ID: 11499259
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concurrence to ACE inhibitors? AT1 receptor blockers and hypertension].
    Heemann U; Kribben A; Phillip T
    Pharm Unserer Zeit; 2001; 30(4):309-12. PubMed ID: 11499256
    [No Abstract]   [Full Text] [Related]  

  • 5. AT1 blockers: are there alternative pathways reducing cardiovascular risk? Introduction.
    van Zwieten PA; Julius S
    J Hypertens Suppl; 2002 Jun; 20(5):S1. PubMed ID: 12184058
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypertensiology 2007].
    Middeke M
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1368-70. PubMed ID: 17570082
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The race for a new target. The human AT1 receptor].
    Gurrath M
    Pharm Unserer Zeit; 2001; 30(4):288-95. PubMed ID: 11499253
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospects for ARB in the next five years.
    Skali H; Pfeffer MA
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):215-8. PubMed ID: 11881126
    [No Abstract]   [Full Text] [Related]  

  • 10. [Can Sartane help a failing heart? AT1-receptor antagonists in cardiac insufficiency].
    Düsing R
    Pharm Unserer Zeit; 2001; 30(4):314-20. PubMed ID: 11499257
    [No Abstract]   [Full Text] [Related]  

  • 11. [Are differences between AT1 antagonists clinically relevant? Dosage, selectivity, metabolism--critically evaluated].
    Dominiak P
    MMW Fortschr Med; 1999 Nov; 141(46):37-8. PubMed ID: 10795143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic basics: the effect of AT1 receptor antagonists].
    Altmannsberger SH; Paneitz A; Siegmund W; Kroemer HK
    Pharm Unserer Zeit; 2001; 30(4):296-302. PubMed ID: 11499254
    [No Abstract]   [Full Text] [Related]  

  • 13. The expanding role of angiotensin receptor blockers in the management of the elderly hypertensive.
    McInnes GT
    Curr Med Res Opin; 2003; 19(5):452-5. PubMed ID: 13678487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What are the consequences of the LIFE Study for general practice].
    Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):48. PubMed ID: 12395704
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of hypertension in patients with atrial fibrillation. Sartan is superior to beta-blocker].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813983
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
    Baer JT; Sauer WH; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
    MMW Fortschr Med; 2002 Sep; 144(38):14. PubMed ID: 12395694
    [No Abstract]   [Full Text] [Related]  

  • 18. [German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists].
    Dominiak P; Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):47. PubMed ID: 12395703
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiovascular system drugs. 5/12/ Angiotensin II antagonists].
    Martin M; Limat S; Woronoff-Lemsi MC
    Soins; 2004; (687):53-4. PubMed ID: 15384783
    [No Abstract]   [Full Text] [Related]  

  • 20. Next generation multifunctional angiotensin receptor blockers.
    Kurtz TW; Klein U
    Hypertens Res; 2009 Oct; 32(10):826-34. PubMed ID: 19713966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.